Biogen expects growth of its keenly watched Alzheimer's disease drug, Leqembi, to see a "linear trend" in the United States ...

In a stunning revelation, researchers find that the fat surrounding our organs might hold the key to understanding ...

"Amyloid immunotherapy has consistently shown an increase in brain volume loss – leading to concerns in the media and medical ...

Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

While we have made progress with FDA approval of two treatments that can slow cognitive decline in early-stage Alzheimer’s ...

Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in ...

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

Scientists have created a game-changing 'Alzheimer's in a dish' model that allows for faster and more accurate testing of ...

In the latest Alzheimer’s research, hidden fat in various parts of the body was shown to be an early warning sign of the ...

Alzheimer’s disease remains one of the most pressing challenges in modern medicine, ranking as a leading cause of death ...

New research has established a link between a specific type of body fat and brain proteins that are hallmarks of Alzheimer’s ...